Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry Road, Stanford University, Stanford,CA 94305-5718, USA.
Int Clin Psychopharmacol. 2010 Jan;25(1):7-16. doi: 10.1097/YIC.0b013e328332055c.
The motivation for clinical trials inventory-depression (MCTI-D) was developed and evaluated for assessing motivations to participate in clinical trials on depression. Sixty-four participants completed the MCTI-D: 40 individuals expressing interest in participating in a randomized clinical trial (RCT); and 24 clinic patients receiving traditional care for depression. Content validity was supported by feedback derived from a panel of experts in depression research and respondents completing the measure. The motivation most frequently endorsed for participating in an RCT was the desire to help others and/or to further science. The potential stigma associated with seeing a psychiatrist was reported to have the least influence. Patients expressed a greater likelihood to participate in RCTs that involved psychotherapy than in experimental medication or placebo-controlled trials. Data from the MCTI-D may provide useful information for depression researchers to consider as possible influences on patients' decisions about whether or not they will participate.
临床研究参与动机量表-抑郁版(MCTI-D)是为评估参与抑郁症临床研究的动机而开发和评估的。共有 64 名参与者完成了 MCTI-D:40 名表示有兴趣参与随机对照试验(RCT)的个体;和 24 名接受传统抑郁症治疗的诊所患者。该量表的内容效度得到了抑郁症研究专家小组和完成该量表的受访者的反馈支持。参与 RCT 的最常见动机是帮助他人和/或推进科学。与看精神科医生相关的潜在耻辱感被认为影响最小。患者表示更有可能参与涉及心理治疗的 RCT,而不是实验性药物或安慰剂对照试验。MCTI-D 的数据可能为抑郁症研究人员提供有用的信息,以考虑这些因素可能对患者是否参与临床试验的决定产生影响。